Cytogenetics and the biological basis of sarcomas

Stephen X. Skapek, Linda G. Shaffer, James A. Barker

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Recently, much research has been directed toward gaining a better understanding of sarcoma biology. To accomplish this goal, researchers have focused on characterizing the cytogenetic abnormalities that are detectable by routine karyotyping. With the use of widely-available molecular biologic tools, new information on the genetic abnormalities of sarcomas is rapidly emerging. In addition, physicians are beginning to successfully apply cytogenetic and molecular biologic findings to clinical settings in the form of molecular diagnostic and prognostic tests. Moreover, detailed study of these genetic abnormalities is leading to a better understanding of the molecular pathology of sarcomas, which may eventually lead to better therapy. In this paper, we will review the important new findings on genetic abnormalities in sarcomas, clinical applications of cytogenetic studies, and insight into the biology of sarcomas.

Original languageEnglish (US)
Pages (from-to)318-325
Number of pages8
JournalCurrent Opinion in Oncology
Volume10
Issue number4
StatePublished - 1998

Fingerprint

Cytogenetics
Sarcoma
Molecular Pathology
Karyotyping
Routine Diagnostic Tests
Chromosome Aberrations
Research Personnel
Physicians
Research
Therapeutics

ASJC Scopus subject areas

  • Cancer Research

Cite this

Skapek, S. X., Shaffer, L. G., & Barker, J. A. (1998). Cytogenetics and the biological basis of sarcomas. Current Opinion in Oncology, 10(4), 318-325.

Cytogenetics and the biological basis of sarcomas. / Skapek, Stephen X.; Shaffer, Linda G.; Barker, James A.

In: Current Opinion in Oncology, Vol. 10, No. 4, 1998, p. 318-325.

Research output: Contribution to journalArticle

Skapek, SX, Shaffer, LG & Barker, JA 1998, 'Cytogenetics and the biological basis of sarcomas', Current Opinion in Oncology, vol. 10, no. 4, pp. 318-325.
Skapek, Stephen X. ; Shaffer, Linda G. ; Barker, James A. / Cytogenetics and the biological basis of sarcomas. In: Current Opinion in Oncology. 1998 ; Vol. 10, No. 4. pp. 318-325.
@article{aede06e8e92542d382d999c396f2f666,
title = "Cytogenetics and the biological basis of sarcomas",
abstract = "Recently, much research has been directed toward gaining a better understanding of sarcoma biology. To accomplish this goal, researchers have focused on characterizing the cytogenetic abnormalities that are detectable by routine karyotyping. With the use of widely-available molecular biologic tools, new information on the genetic abnormalities of sarcomas is rapidly emerging. In addition, physicians are beginning to successfully apply cytogenetic and molecular biologic findings to clinical settings in the form of molecular diagnostic and prognostic tests. Moreover, detailed study of these genetic abnormalities is leading to a better understanding of the molecular pathology of sarcomas, which may eventually lead to better therapy. In this paper, we will review the important new findings on genetic abnormalities in sarcomas, clinical applications of cytogenetic studies, and insight into the biology of sarcomas.",
author = "Skapek, {Stephen X.} and Shaffer, {Linda G.} and Barker, {James A.}",
year = "1998",
language = "English (US)",
volume = "10",
pages = "318--325",
journal = "Current Opinion in Oncology",
issn = "1040-8746",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Cytogenetics and the biological basis of sarcomas

AU - Skapek, Stephen X.

AU - Shaffer, Linda G.

AU - Barker, James A.

PY - 1998

Y1 - 1998

N2 - Recently, much research has been directed toward gaining a better understanding of sarcoma biology. To accomplish this goal, researchers have focused on characterizing the cytogenetic abnormalities that are detectable by routine karyotyping. With the use of widely-available molecular biologic tools, new information on the genetic abnormalities of sarcomas is rapidly emerging. In addition, physicians are beginning to successfully apply cytogenetic and molecular biologic findings to clinical settings in the form of molecular diagnostic and prognostic tests. Moreover, detailed study of these genetic abnormalities is leading to a better understanding of the molecular pathology of sarcomas, which may eventually lead to better therapy. In this paper, we will review the important new findings on genetic abnormalities in sarcomas, clinical applications of cytogenetic studies, and insight into the biology of sarcomas.

AB - Recently, much research has been directed toward gaining a better understanding of sarcoma biology. To accomplish this goal, researchers have focused on characterizing the cytogenetic abnormalities that are detectable by routine karyotyping. With the use of widely-available molecular biologic tools, new information on the genetic abnormalities of sarcomas is rapidly emerging. In addition, physicians are beginning to successfully apply cytogenetic and molecular biologic findings to clinical settings in the form of molecular diagnostic and prognostic tests. Moreover, detailed study of these genetic abnormalities is leading to a better understanding of the molecular pathology of sarcomas, which may eventually lead to better therapy. In this paper, we will review the important new findings on genetic abnormalities in sarcomas, clinical applications of cytogenetic studies, and insight into the biology of sarcomas.

UR - http://www.scopus.com/inward/record.url?scp=0031926172&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031926172&partnerID=8YFLogxK

M3 - Article

VL - 10

SP - 318

EP - 325

JO - Current Opinion in Oncology

JF - Current Opinion in Oncology

SN - 1040-8746

IS - 4

ER -